- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Genentech MEK inhibitor
Total 110118 results
-
M.D. Anderson Cancer CenterGenentech, Inc.; Vanderbilt-Ingram Cancer CenterCompletedLung CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedNon-Hodgkin's LymphomaUnited States
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
Soll EyeGenentech, Inc.CompletedCYSTOID MACULAR EDEMAUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.CompletedRespiratory Failure | Acute Respiratory Distress Syndrome | Acute Lung InjuryUnited States
-
Mohammed M MilhemGenentech, Inc.CompletedSarcoma | Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced Sarcoma | Unresectable SarcomaUnited States
-
Bhuvaneswari RamaswamyUniversity of Pittsburgh; Genentech, Inc.; Case Comprehensive Cancer CenterCompleted
-
Nemours Children's ClinicNovartis; Pfizer; AstraZeneca; Genentech, Inc.; Thrasher Research FundCompletedIdiopathic Short StatureUnited States, Chile
-
National Cancer Institute (NCI)M.D. Anderson Cancer Center; Washington University School of Medicine; Merck... and other collaboratorsCompletedMalignant Glioma | Recurrent GlioblastomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Papillary Serous Mullerian Tumor | Clear Cell Mullerian TumorUnited States
-
Ohio State University Comprehensive Cancer CenterGenentech, Inc.; Celgene CorporationCompleted
-
Medical University of South CarolinaTerminated
-
Genentech, Inc.Terminated
-
Genentech, Inc.CompletedInfluenzaSpain, United Kingdom, Korea, Republic of, Belgium, Czechia, Canada, Netherlands, Hong Kong, New Zealand, Peru, Germany, France, Israel, Hungary, South Africa, Sweden, Mexico, Taiwan, Brazil, Bulgaria, Chile, Italy, Poland, Russian Federation and more
-
University of California, DavisGenentech, Inc.Completed
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedSolid TumorsUnited States
-
Milton S. Hershey Medical CenterGenentech, Inc.CompletedPancreatic CancerUnited States
-
Genentech, Inc.Breast International Group; SOLTI Breast Cancer Research Group; Austrian Breast...CompletedBreast CancerUnited States, United Kingdom, Germany, Australia, Austria, Belgium, Brazil, France, Guatemala, Italy, Korea, Republic of, Panama, Poland, Portugal, Spain, Czechia, Hungary, Mexico, Peru, Switzerland, El Salvador, Chile
-
Inova Health Care ServicesGenentech, Inc.Withdrawn
-
Children's Hospital Medical Center, CincinnatiGenentech, Inc.CompletedDiffuse Intrinsic Pontine Glioma | Newly Diagnosed High-Grade GliomasUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Hoffmann-La... and other collaboratorsCompletedBiliary Tract Cancer | Gallbladder AdenocarcinomaUnited States
-
Genentech, Inc.Completed
-
Ohio State University Comprehensive Cancer CenterGenentech, Inc.; National Comprehensive Cancer NetworkCompletedBreast CancerUnited States
-
Genentech, Inc.CompletedSolid TumorUnited States, France
-
Stanford UniversityGenentech, Inc.TerminatedSoft Tissue Sarcoma | AngiosarcomasUnited States
-
Wills EyeGenentech, Inc.; Novartis PharmaceuticalsCompleted
-
Emory UniversityNational Cancer Institute (NCI); Genentech, Inc.CompletedHead and Neck CancerUnited States
-
UConn HealthGenentech, Inc.TerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Stage 4 Cancer | Stage 3 CancerUnited States
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-small Cell Lung CancerUnited States
-
Hoosier Cancer Research NetworkBayer; Genentech, Inc.; AmgenTerminatedMetastatic Breast CancerUnited States
-
Ritu SalaniGenentech, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; National Institutes of Health (NIH)CompletedBrain Cancer | Malignant GliomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.CompletedCarcinoma, Non-small-cell LungUnited States
-
University of California, DavisNational Cancer Institute (NCI); Genentech, Inc.CompletedPancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
Masonic Cancer Center, University of MinnesotaEli Lilly and Company; Genentech, Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States
-
Ohio State University Comprehensive Cancer CenterGenentech, Inc.CompletedOSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungUnited States
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
AbbVieGenentech, Inc.Completed
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Melissa Burgess, MDGenentech, Inc.TerminatedActive Melanoma Brain MetastasesUnited States
-
Safi ShahdaBayer; Genentech, Inc.CompletedSOLID TUMORSUnited States
-
Medical University of South CarolinaCompletedLiver CancerUnited States
-
University of California, San FranciscoGenentech, Inc.CompletedGlioblastoma Multiforme | GliosarcomaUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
David O'MalleyGenentech, Inc.CompletedEndometrial CancerUnited States